Pharmacists in the Channel Islands have confirmed they are dealing with an ongoing shortage of a drug used by cancer patients.
It follows a shortage of Creon, a pancreatic enzyme replacement therapy (Pert), being described by pharmacists in the UK as “one of the worst” examples of a medicine shortage.
The drug does not treat cancer but is used by patients with pancreatic cancer, cystic fibrosis and chronic pancreatitis to help with digestion.
A spokesperson from the Guernsey Prescribing Support Unit said there have been ongoing supply issues with Pert since summer 2024, with the department of health in England issuing a national patient safety alert in December 2024.